DiscoverThe Finimize Daily BriefSpaceX Is Pushing Ahead With Its IPO Plans, And The Biotech Sector Has Seen The Most Dealmaking In A Decade
SpaceX Is Pushing Ahead With Its IPO Plans, And The Biotech Sector Has Seen The Most Dealmaking In A Decade

SpaceX Is Pushing Ahead With Its IPO Plans, And The Biotech Sector Has Seen The Most Dealmaking In A Decade

Update: 2025-12-11
Share

Description

SpaceX is pushing ahead with its initial public offering plans – a bid to raise some $30 billion and land in the $1.5 trillion club – while the biotech sector has seen the most mergers and acquisitions in a decade, as pharma firms race against an expiry date.

Today’s stories:

Try Finimize Pro

Comments 
In Channel
loading
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

SpaceX Is Pushing Ahead With Its IPO Plans, And The Biotech Sector Has Seen The Most Dealmaking In A Decade

SpaceX Is Pushing Ahead With Its IPO Plans, And The Biotech Sector Has Seen The Most Dealmaking In A Decade

Finimize